KLRS
insider transactionsKalaris Therapeutics, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Cluster buy signal: Multiple insiders at the same company buying around the same time — often a stronger signal than a single buy. 2 different insiders made open-market purchases in the last 365 days, totalling $6.2M.
Net shares · 365d
+722.2K
724.1K buy · 1.9K sell
Net value · 365d
$6.2M
$6.2M in · $12.9K out
Sentiment · 365d
Net buying
100% buying · 0% selling
Open-market trades · 365d
3
724.1K buy · 1.9K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
Transactions · 365d
-
Buy·P
Director, 10% Owner
$1.2M
244.3K sh · $4.83
Own +12%
-
Buy·P
Samsara Opportunity Fund, L.P.
TenPercentOwner
$5.0M
479.8K sh · $10.42
Own +32%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 20, 2026 | AKKARAJU SRINIVAS | Buy P | 244.3K | $1.2M |
| Dec 18, 2025 | Samsara Opportunity Fund, L.P. | Buy P | 479.8K | $5.0M |
Buy Sell Non-market (grant · exercise · gift)
About KLRS insider trading
This page tracks insider transactions for Kalaris Therapeutics, Inc. (KLRS) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.